| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |